FDA Says Correction By Baxter Due To Increase In Reported False Upstream Occlusion Alarms Following Software Upgrades In Spectrum V8 & IQ Infusion Pumps
Portfolio Pulse from Happy Mohamed
The FDA has reported that Baxter International Inc. has made a correction due to an increase in false upstream occlusion alarms following software upgrades in Spectrum V8 & IQ Infusion Pumps.
July 31, 2023 | 1:48 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Baxter International Inc. has made a correction to its Spectrum V8 & IQ Infusion Pumps software following an increase in false alarms. This could potentially affect the company's reputation and sales.
The news directly pertains to Baxter International Inc. and its products. The correction of a software issue indicates a potential flaw in the product, which could negatively impact the company's reputation and sales in the short term. However, the company's proactive response may mitigate some of this impact.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100